Comparison between Infibeam Incorporation IPO and Thyrocare Technologies IPO.
Infibeam Incorporation IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Thyrocare Technologies IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Infibeam Incorporation IPO is up to ₹450.00 Cr whereas the issue size of the Thyrocare Technologies IPO is up to ₹479.21 Cr. The final issue price of Infibeam Incorporation IPO is ₹432.00 per share and of Thyrocare Technologies IPO is ₹446.00 per share.
| Infibeam Incorporation IPO | Thyrocare Technologies IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹360.00 per share | ₹420.00 per share |
| Issue Price (Upper) | ₹432.00 per share | ₹446.00 per share |
| Issue Price (Final) | ₹432.00 per share | ₹446.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 34 shares | 33 shares |
| Fresh Issue Size | 1,04,16,666 shares | 0 shares |
| Fresh Issue Size (Amount) | up to ₹450.00 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 0 shares | 1,07,44,708 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹479.21 Cr |
| Issue Size Total | 1,04,16,666 shares | 1,07,44,708 shares |
| Issue Size Total (Amount) | up to ₹450.00 Cr | up to ₹479.21 Cr |
Infibeam Incorporation IPO opens on Mar 21, 2016, while Thyrocare Technologies IPO opens on Apr 27, 2016. The closing date of Infibeam Incorporation IPO and Thyrocare Technologies IPO is Mar 23, 2016, and Apr 29, 2016, respectively.
| Infibeam Incorporation IPO | Thyrocare Technologies IPO | |
|---|---|---|
| Anchor Bid Date | Apr 26, 2016 | |
| Issue Open | Mar 21, 2016 | Apr 27, 2016 |
| Issue Close | Mar 23, 2016 | Apr 29, 2016 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | Apr 04, 2016 | May 09, 2016 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Infibeam Incorporation IPO P/E ratio is , as compared to Thyrocare Technologies IPO P/E ratio of .
| Infibeam Incorporation IPO | Thyrocare Technologies IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 64.96 | |||||
| Promoter Shareholding (Post-Issue) | 63.96 | |||||
| P/E Ratio | ||||||
| Market Cap | ₹2293.55 Cr. | ₹2396.07 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW | 17.37 |
In the Infibeam Incorporation IPO Retail Individual Investors (RII) are offered 10,41,666 shares while in Thyrocare Technologies IPO retail investors are offered 10,41,666 shares. Qualified Institutional Buyers (QIB) are offered 78,12,501 shares in Infibeam Incorporation IPO and 21,48,942 shares in Thyrocare Technologies IPO.
| Infibeam Incorporation IPO | Thyrocare Technologies IPO | |
|---|---|---|
| Anchor Investor Reservation | 32,23,411 shares | |
| Market Maker Reservation | ||
| QIB | 78,12,501 shares | 21,48,942 shares |
| NII | 15,62,499 shares | 16,11,707 shares |
| RII | 10,41,666 shares | 37,60,648 shares |
| Employee | ||
| Others | ||
| Total | 1,04,16,666 shares | 1,07,44,708 shares |
Infibeam Incorporation IPO subscribed 1.11x in total, whereas Thyrocare Technologies IPO subscribed 73.55x.
| Infibeam Incorporation IPO | Thyrocare Technologies IPO | |
|---|---|---|
| QIB (times) | 0.86x | 73.18x |
| NII (times) | 2.23x | 225.30x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 1.31x | 8.73x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 1.11x | 73.55x |
